Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
about
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive reviewExosome-mediated small RNA delivery for gene therapyOcular Complications of Diabetes and Therapeutic ApproachesPopulation pharmacokinetics of pegaptanib sodium (Macugen(®)) in patients with diabetic macular edema.
P2860
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
@ast
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
@en
type
label
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
@ast
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
@en
prefLabel
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
@ast
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
@en
P2860
P1476
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
@en
P2093
Rupal Morjaria
P2860
P304
P356
10.1517/17425255.2014.922543
P407
P577
2014-05-24T00:00:00Z